ANGIOTAX-PLUS trial: A randomized phase II trial assessing the activity of weekly paclitaxel (WP) plus or minus bevacizumab ( B) in advanced angiosarcoma (AS).

Affiliation auteurs!!!! Error affiliation !!!!
TitreANGIOTAX-PLUS trial: A randomized phase II trial assessing the activity of weekly paclitaxel (WP) plus or minus bevacizumab ( B) in advanced angiosarcoma (AS).
Type de publicationJournal Article
Year of Publication2014
AuteursPenel N, Blay J-Y, Mir O, Tresch E, Bompas E, Domont J, Cassier PAlexandre, Rolland F, Piperno-Neumann S, Italiano A, Chevreau C, Cupissol D, Bay J-O, Collard O, Saada E, Bertucci F, Isambert N, Delcambre C, Clisant S, Ray-Coquard ILaure, GETO FSarcoma Gr
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume32
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2014.32.15_suppl.10501